Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22893941 | 0.92 | NPC1 (0.36) | NPC1RAB9AMAPTKDM4EALDH1A1 | |
| SCHEMBL22893999 | 0.90 | KDM4E (0.36) | NPC1RAB9AMAPTKDM4EALDH1A1 | |
| SCHEMBL22893884 | 0.89 | ALDH1A1 (0.33) | MAPTKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL21923541 | 0.87 | ALDH1A1 (0.34) | NPC1RAB9AMAPTKDM4EALDH1A1 | |
| SCHEMBL22894110 | 0.86 | KDM4E (0.38) | NPC1RAB9AMAPTKDM4EALDH1A1 | |
| SCHEMBL22894085 | 0.86 | ALDH1A1 (0.33) | MAPTKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL19239415 | 0.85 | KDM4E (0.34) | MAPTKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL22893945 | 0.85 | NPC1 (0.33) | NPC1RAB9AL3MBTL1 | |
| SCHEMBL19239413 | 0.85 | PDE10A (0.36) | MAPTKDM4EALDH1A1HPGDNPSR1 | |
| SCHEMBL22893974 | 0.85 | KDM4E (0.31) | MAPTKDM4EALDH1A1HPGDNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210013411-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210013411-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | NPC1 2657/4885RAB9A 2195/4885MAPT 1428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.